Evidence map›Paper›PMID 23551043›Full record

ArticleEpilepsia2013

A quantitative study of white matter hypomyelination and oligodendroglial maturation in focal cortical dysplasia type II.

Caterina Shepherd, Joan Liu, Joanna Goc, Lillian Martinian, Thomas S Jacques, Sanjay M Sisodiya, Maria Thom

Abstract read
In one paragraph

Article in Epilepsia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.Journal of neuropathology and experimental neurology · 2020
    Article
  11. Neuroproteomics in Epilepsy: What Do We Know so Far?Frontiers in molecular neuroscience · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Doublecortin-expressing cell types in temporal lobe epilepsy.Acta neuropathologica communications · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. A Novel Focal Seizure Pattern Generated in Superficial Layers of the Olfactory Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Caterina ShepherdDepartment of Clinical and Experimental Epilepsy, UCL, Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Joan Liu
Joanna Goc
Lillian Martinian
Thomas S Jacques
Sanjay M Sisodiya
Maria Thom
National Hospital for Neurology and Neurosurgery · GBUniversity College London · GB

Funding

Department of HealthMedical Research Council MR/J01270X/1
6 · The paper itself

Abstract

purposeA diagnostic feature of focal cortical dysplasia (FCD) type II on magnetic resonance imaging (MRI) is increased subcortical white matter (WM) signal on T2 sequences corresponding to hypomyelination, the cause of which is unknown. We aimed to quantify WM pathology in FCD type II and any deficiency in the numbers and differentiation of oligodendroglial (OL) cell types within the dysplasia.

methodsIn 19 cases we defined four regions of interests (ROIs): ROI1 = abnormal WM beneath dysplasia, ROI2 =dysplastic cortex, ROI3 = normal WM, and ROI4 = normal cortex. We quantified axonal and myelin density using immunohistochemistry for neurofilament, myelin basic protein and quantified mature OL with NogoA, cyclic nucleotide 3-phosphodiesterase (CNPase) and OL precursor cell (OPC) densities with platelet derived growth factor receptor (PDGFR)α, β and NG-2 in each region. KEY

findingsWe observed a significant reduction in myelin and axons in the WM beneath dysplasia relative to normal WM and there was a correlation between relative reduction of myelin and neurofilament in each case. OL and OPC were present in the WM beneath dysplasia and although present in lower numbers with most markers, were not significantly different from normal WM. Neurofilament and myelin labeling highlighted disorganized orientation of fibers in dysplastic cortex but there were no significant quantitative differences compared to normal cortex. Clinical correlations showed an association between the severity of reduction of myelin and axons in the WM of FCD and duration of epilepsy. SIGNIFICANCE: These findings indicate a reduction of myelinated axons in the WM of FCD type II rather than dysmyelination as the primary pathologic process underlying WM abnormalities, possibly influenced by duration of seizures. The range of OPC to OL present in FCD type II does not implicate a primary failure of cell recruitment and differentiation of these cell types in this pathology.

Indexed as

2',3'-Cyclic-Nucleotide PhosphodiesterasesAdolescentAdultAgedAntigensBrainBrain DiseasesChildChondroitin Sulfate Proteoglycan 4EpilepsyFemaleHumansLeukocyte Common AntigensMagnetic Resonance ImagingMaleMalformations of Cortical Development2',3'-Cyclic-Nucleotide PhosphodiesterasesAntigensChondroitin Sulfate Proteoglycan 4Leukocyte Common AntigensMyelin Basic ProteinMyelin ProteinsNerve Tissue ProteinsNogo ProteinsProteoglycansReceptor, Platelet-Derived Growth Factor alphaRTN4 protein, human

Identifiers

PMID23551043
PMCPMC4165267
OpenAlexW2022112744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.